|ORIGINAL RESEARCH REPORT
|Year : 2021 | Volume
| Issue : 2 | Page : 113-116
Histopathological analysis of male breast cancer in Southwestern Nigeria: A single-center retrospective study
Mustapha Akanji Ajani1, Segun Samson Odetola2, Babatope L Awosusi2, Ebenezer O Fatunla2, Ayodeji A Salami1
1 Department of Pathology, University College Hospital; Department of Pathology, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria
2 Department of Pathology, University College Hospital, Ibadan, Oyo State, Nigeria
|Date of Submission||27-Aug-2020|
|Date of Acceptance||01-Dec-2020|
|Date of Web Publication||24-Apr-2021|
Dr. Mustapha Akanji Ajani
Department of Pathology, College of Medicine, University of Ibadan and University College Hospital, Ibadan, Oyo state
Source of Support: None, Conflict of Interest: None
Background: Breast cancer in men is still an uncommon and largely understudied disease. It accounts for 1% of all breast cancers. The aim of this study was to review all the male breast cancer cases diagnosed at the tertiary medical institution in South West Nigeria over a 10-year period and to compare the findings with other similar studies done in Nigeria and globally. Methods: We retrospectively reviewed all histologically diagnosed cases of male breast cancers in the Department of Pathology, Tertiary Medical Institution in South West Nigeria over a 10-year period from January 1, 2009, to December 31, 2018. Clinicopathological parameters including patients' age, laterality, and specific histological sub-types were extracted from surgical day book and Cancer Registry of the Department. The data were analyzed using the IBM SPSS Statistics (version 22; IBM Corporation, Armonk, New York, USA). The results were subsequently presented in tables, relative frequencies, group percentages, and photomicrographs. Results: Forty-two cases of male breast cancer were seen accounting for 1.7% of all breast cancer cases. The age range was between 22 and 91 years with a mean age of 60.3 years, and a peak occurrence was in the 8th decade. The right breast was more affected than the left accounting for 52% of the total number of cases seen. The most common histological sub-type found was invasive ductal carcinoma accounting for 88% of all the cases. Conclusion: Male breast cancer is relatively uncommon compared to female breast cancer. It is more common in the older age group, and invasive ductal carcinoma is still the most common histological subtype.
Keywords: Ibadan, invasive ductal carcinoma, male breast cancer, male breast carcinoma, Nigeria
|How to cite this article:|
Ajani MA, Odetola SS, Awosusi BL, Fatunla EO, Salami AA. Histopathological analysis of male breast cancer in Southwestern Nigeria: A single-center retrospective study. J Clin Sci 2021;18:113-6
|How to cite this URL:|
Ajani MA, Odetola SS, Awosusi BL, Fatunla EO, Salami AA. Histopathological analysis of male breast cancer in Southwestern Nigeria: A single-center retrospective study. J Clin Sci [serial online] 2021 [cited 2021 Jun 15];18:113-6. Available from: https://www.jcsjournal.org/text.asp?2021/18/2/113/314454
| Introduction|| |
Breast cancer is one of the most prevalent malignancies with a high annual mortality rate in men and women. It still poses a threat to human life even with introduction of various treatment modalities. Male breast cancer in men is still an uncommon and largely understudied disease. Only very few prospective studies focusing on breast cancer in men have been conducted. This is because breast cancer is still seen largely as a cancer that affects the female gender.,
Male breast cancer accounts for approximately 1% of all breast cancer cases. In 2018, an estimated 2500 incident breast cancer was estimated to be diagnosed in men in the United States, and approximately 500 men are expected to die from this disease. Data from the Surveillance, Epidemiology, and End Results program indicated that the age-adjusted incidence rate has increased from 0.85 cases per 100,000 men in the general population in 1975 to a high of 1.43 cases per 100,000 in 2011. The lifetime risk of breast cancer for a man is approximately 1:1000, as compared with 1:8 for a woman. As is the case with many cancers, breast cancer in men is an age-related disease, with incidence rates rising steadily with age. The incidence of male breast cancer shows an increase in advanced ages and remains steady until it reaches a plateau around age 80. Male breast cancer has increased in recent years with an increased incidence rate of 26% over the past 25 years. The average age at diagnosis is approximately 5 years older for men than for women (67 years for men vs. 62 years for women).
Black men appear to be at greater risk than non-Hispanic white men., The risk of breast cancer is doubled for men who have a first-degree relative with the disease. The risk factors for breast cancer includes radiation exposure, increased serum estradiol, Klinefelters syndrome, gynaecomastia, liver disease, obesity, and testicular abnormalities. Similarly, a history of breast cancer in a male first-degree relative is associated with an increased risk of breast cancer in men. Mutations in BRCA are among the most clearly established risk factors for breast cancer in men. Population-based studies have shown that 0%–4% of men with breast cancer have BRCA1 mutations, and 4%–16% have BRCA2 mutations.,,
Few studies have been done in Southwestern Nigeria to review the incidence and clinicopathological features of male breast cancer.,,,,,, Aghadiuno in a previous study from Ibadan reported that male breast cancer accounts for 0.4% of all male neoplasia in Ibadan and about 3.4% of all breast cancers in both females and males.
The aim of the present study was to review all the histologically diagnosed male breast cancer cases at the University College Hospital Ibadan over a 10-year period which would serve as an update of the earlier study and to compare the findings with other similar studies done in Nigeria and globally.
| Methods|| |
This was a 10-year hospital-based retrospective study that was designed to review all histologically diagnosed cases of male breast cancers in the Department of Pathology, tertiary medical institution in South-west Nigeria from January 1, 2009, to December 31, 2018.
Cases with missing bio-data and cases in which histology slides and/or FFPE tissue blocks could not be found were excluded from the study. Clinical and pathological data were extracted from the surgical day book, histology request cards, and the Cancer Registry of the Department. Histology slides were reviewed by two pathologists. The data were analyzed using the IBM SPSS Statistics (version 22; IBM Corporation, Armonk, New York, USA). The results obtained were subsequently presented in tables, relative frequencies, group percentages, and photomicrographs. Ethical approval was not indicated for this study. The data extracted did not violate the principles of confidentiality on patients' information or diagnosis.
| Results|| |
A total of 42 cases of male breast cancer were seen, accounting for 1.7% of all breast cancer cases. The age range was between 22 and 91 years with a mean age of 60.3 years and a peak occurrence in the 8th decade. Patients in the 9th and 10th decades of life had the lowest frequency of breast cancer cases representing 2.4% of the cases seen, respectively, for each age group [Table 1]. Most of the cases affected are from the right breast accounting for 52% of the total number of cases seen. Most of the patients presented with a retro-areola lump/mass. The most common histological sub-type found in this study is the invasive ductal carcinoma [Figure 1] accounting for 88% of the cases seen [Table 2]. There was a case each of invasive lobular carcinoma, microinvasive carcinoma, and spindle cell sarcoma accounting for 2.4% of the cases seen, respectively. There were also two cases of mucinous carcinoma [Figure 2] accounting for 4.8% of all the breast cancer cases seen. The peak incidence of male breast cancer cases was in 2013 with eight cases while the least incidence of two cases each was seen in the years 2012 and 2016 [Figure 3].
|Figure 1: Photomicrograph showing invasive ductal carcinoma of the male breast (H and E, ×100)|
Click here to view
|Figure 2: Photomicrograph showing nests of malignant epithelial cells in a pool of mucin consistent with mucinous carcinoma of the male breast (H and E, ×100)|
Click here to view
| Discussion|| |
The male breast is still subject to neoplastic changes simulating the female counterpart but attention has however been focused mainly on the female lesions. Only few reports are available on male breast cancer leading to the erroneous impression that the disease is entirely a female problem. Breast cancer in men accounts for approximately 1% of all breast cancer cases worldwide. It is said to be more frequent in sub-Saharan Africa, accounting for 4%–13% of all breast cancer cases seen. In this study, male breast cancer cases accounted for 1.7% of all breast cancer cases seen, and this finding compares favorably with similar studies done in other parts of Nigeria. However, a similar earlier study from the same center reported a higher prevalence rate of 3.4% of all breast cancer cases.
A study from Lagos by Orah and Daramola reported an almost similar prevalence rate of 1.6%, while two separate studies from Ile-Ife by Adeniyi et al. and Adisa et al. reported slightly higher prevalence rates of 1.9% and 2.4%, respectively. Ajayi et al. in Lagos and Ezeome et al. in Enugu also reported slightly higher rates of 2.4% and 2%, respectively. However, some studies reported clearly higher prevalence rates. Oguntola et al. reported a rate of 8.86% in a study done in Oshogbo while Hassen and Mabogunje and Ahmed et al. reported a rate of 9% each form two separate studies done in Zaria. Hypoestrogenism has been linked to the higher incidence of male breast cancer in African cohort, and this has been causally linked to endemic liver infections in Africa.
The wide age range of patients seen in this study from 22 to 91 years was also similar to what other studies have reported. Akosa et al. and Kidmas et al. reported age ranges of 32–79 and 12–85 years, respectively, while Ezeome et al. and Dogo et al. reported age ranges of 25–84 years and 19–80 years, respectively. The peak age of occurrence for male breast cancer in this study center was in the 8th decade, this was a decade later than that what was reported by Ezeome et al., while Kidmas et al. and Dogo et al. reported a lower peak age of occurrence in the 5th decade. The mean age of 60.3 years seen in this study was also consistent with what some studies have reported. Oguntola et al. and Ezeome et al. both reported a mean age of 60.5 years while Adisa et al. and Olu-Eddo and Momoh reported mean ages of 64.7 years and 64.4 years, respectively. Ihekwaba reported a lower mean age of 54 years.
In this study, there was a slight right-sided predominance in the male breast cancer cases representing 52% of all cases seen while 48% of the cases are left sided. This was somewhat similar to reports from Jos where Kidmas et al. reported a preponderance of right-sided breast cancers in males accounting for 58% of the cases seen. However, Ezeome et al. in Enugu reported a left side preponderance accounting for 54% of the cases seen. No case of bilateral breast cancer in males was seen in this study; however, Olu-Eddo and Momoh in Benin reported bilaterality in 12.5% of cases seen.
The most common histological subtype of breast cancer in this study was invasive ductal carcinoma which accounted for 88% of all the cases seen. This was consistent with what other studies have also reported. Mucinous carcinoma accounted for 4.8% of all male breast cancer cases seen in this study. A similar study by Dogo et al. in Maiduguri reported that mucinous carcinoma accounted for 4.2% of the cases while mucinous carcinoma accounted for 11% of the male breast cancer cases in a study done in Ghana by Akosa et al. There was only one case of spindle cell sarcoma seen representing 2.4% of all cases, this contrasts sharply with a higher value of 7.7% for male breast sarcoma reported in Jos by Kidmas et al.
Comparison of the overall prognoses for male and female breast carcinoma patients is controversial. Studies reporting a worse prognosis for males have suggested that the anatomy of the male breast may provide less of a barrier to metastases or that more aggressive tumor biology may be the basis of survival variation. However, others have found that, once separated according to stage or lymph node involvement, the prognosis is the same., Although our study did not look at the clinical outcomes or survival rates of the diagnosed cases, an earlier study in Ibadan reported a 5-year survival rate of 7%. The reasons for the poor prognosis and outcomes in male breast cancer cases include late presentation, advanced disease, and ineffectiveness of chemotherapy in diagnosed cases.
| Conclusion|| |
Breast cancer in men is relatively uncommon compared to female breast cancers; however, they share similar clinico-pathological features. Male breast cancers are more common in the older age group and invasive ductal carcinoma is still the most common histological subtype seen. Many gaps still remain in our knowledge about breast cancers in men.
This study is a baseline retrospective histopathological study which will open up to further studies on immunohistochemical and genetic analysis (to determine the hormone receptors and mutations) of the cases of male breast cancer in future.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Mirmalek SA, Elham KF. Clinical application of breast cancer biology review of literature. Iran J Surg 2010;17:1-17.
Giordano HS. Breast cancer in men. N Engl J Med 2018;378:2311-20.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30.
Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:20-6.
Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: A population-based study. Cancer 2004;101:51-7.
O'Malley C, Shema S, White E, Glaser S. Incidence of male breast cancer in California, 1988-2000: Racial/ethnic variation in 1759 men. Breast Cancer Res Treat 2005;93:145-50.
Shahidsales S, Ersi MF. Male breast cancer: A review of literature. Rev Clin Med 2017;4:69-72.
Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, et al
. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997;60:313-9.
Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, et al
. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: A population-based study in Italy. Cancer Res 2003;63:342-7.
Aghadiuno PU. Cancer of the male breast: Analysis of forty-three cases in Ibadan, Nigeria. Afr J Med Med Sci 1987;16:15-26.
Oguntola AS, Aderonmu AO, Adeoti ML, Olatoke SA, Akanbi O, Agodirin SO. Male breast cancer in LAUTECH teaching hospital Osogbo, South Western Nigeria. Niger Postgrad Med J 2009;16:166-70.
Orah N, Daramola AO. Histologic and immunohistochemical characteristics of male breast cancer at Lagos University Teaching Hospital. A retrospective study. Niger Med Pract 2016;70:67-70.
Adeniyi KA, Adelusola KA, Odesanmi WO, Fadiran OA. Histopathological analysis of carcinoma of the male breast in Ile-Ife, Nigeria. East Afr Med J 1997;74:455-7.
Ihekwaba FN. The management of male breast cancer in Nigerians. Postgrad Med J 1993;69:562-5.
Adisa AO, Arowolo OA, Alatise OI, Lawal OO, Adesunkanmi AR. Clinical pattern of male breast cancer in Ile-Ife, Nigeria. Sahel Med J 2008;11:24-7. [Full text]
Ajayi DO, Osegbe DN, Ademiluyi SA. Carcinoma of the male breast in West Africans and a review of World Literature. Cancer 1982;50:1664-7.
Umoh MS, Asuquo ME, Otu A, Ekanem I. Male breast cancer in Calabar Nigeria: A twenty-year experience (1983-2002). Glob J Community Med 2009;2:21-5.
Zongo N, Ouédraogo S, Korsaga-Some N, Some OR, Go N, Ouangre E, et al
. Male breast cancer: Diagnosis stages, treatment and survival in a country with limited resources (Burkina Faso). World J Surg Oncol 2018;16:4.
Ezeome ER, Emegoakor CD, Chianakwana GU, Anyanwu S. The pattern of male breast cancer in eastern Nigeria: A 12-year review. Niger Med J 2010;51:26-9. [Full text]
Hassen I, Mabogunje O. Cancer of the male breast in Zaria, Nigeria. East Afr Med J 1995;72:457-8.
Ahmed A, Ukwenya Y, Abdullahi A, Muhammad I. Management and outcomes of male breast cancer in Zaria, Nigeria. Int J Breast Cancer 2012;2012:845143.
Culell P, Solernou L, Tarazona J, Roma J, Martí E, Miguel A, et al
. Male breast cancer: A multicentric study. Breast J 2007;13:213-5.
Akosa AB, van Norden SV, Tettey Y. Hormone receptor expression in male breast cancers. Ghana Med J 2005;39:14-9.
Kidmas AT, Ugwu BT, Manasseh AN, Iya D, Opaluwa AS. Male breast malignancy in Jos University Teaching Hospital. West Afr J Med 2005;24:36-40.
Dogo D, Gali BM, Ail N, Nggada HA. Male breast cancer in North Eastern Nigeria. Niger J Clin Pract 2006;9:139-41.
Olu-Eddo AN, Momoh MI. Clinicopathological study of male breast cancer in Nigerians and a review of the literature. Nig Q J Hosp Med 2010;20:121-4.
Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: A review of 229 patients who presented to the princess Margaret hospital during 40 years: 1955-1996. Cancer 1999;85:629-39.
Stierer M, Rosen H, Weitensfelder W, Hausmaninger H, Teleky B, Jakesz R, et al
. Male breast cancer: Austrian experience. World J Surg 1995;19:687-93.
Cutuli B, Lacroze M, Dilhuydy JM, Velten M, de Lafontan B, Marchal C, et al
. Male breast cancer: Results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995;31A: 1960-4.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2]